Human Rabies Vaccine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
Rabies is a severe disease caused by the rabies virus belonging to family Rhabodoviridae. Rabies is primarily a disease found in animals; however, humans too can be infected through bites of animals such as dogs, raccoons, cats, foxes, bats, and other mammals. Rabies virus infects the central nervous system causing disease in the brain, ultimately leading to death. The early symptoms of rabies are similar to those of other diseases; however, as the disease progresses, specific symptoms appear such as hallucination, insomnia, anxiety, paralysis hyper salivation, hydrophobia etc. Rabies can be prevented by vaccine which is made from inactivated rabies virus. The vaccine is prescribed for high-risk people. It is also given to a person after exposure to the disease for prevention of rabies.
The global human rabies vaccine market is estimated to grow at a significant rate during the forecast period. According to WHO, in 99% of the cases, pet dogs are responsible for the transmission of the virus to humans. Adoption of dogs as pets is a popular trend across the world. Therefore, it is a driving factor of the growth of global human rabies vaccine market. Rise in number of adoption of pets such as dogs, cats, etc. Globally, incidence of human rabies in developing countries, prevalence of animal bite incidences, etc. are expected to propel the global human rabies vaccine market during the forecast period. Furthermore, rise in awareness about the disease, government initiatives to eradicate the disease, entry of new vaccine manufacturers, development in R&D, etc. are the other factors fuelling the growth of the global market through 2025. However, factors such as stringent government regulation regarding efficacy and safety and lack of supply of the vaccine in remote areas are anticipated to be the major restraints of global human rabies vaccine market during the forecast period.
The global human rabies vaccine market can be segmented into cell line type, application, distribution channel, and region. On the basis of cell line type, the global human rabies vaccine market can be divided into chick embryo cells, Vero cell, BHK cells, and others. Vero cell line vaccine is anticipated to hold a significant share of the global market due feasibility of Vero cells. Based on application, the global human rabies vaccine market can be classified into post-exposure prophylaxis and pre-exposure prophylaxis. Based on the distribution channel the global market can be divided into hospital pharmacies, retail pharmacies, and e-commerce.
Geographically, the global human rabies vaccine market can be divided into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is projected to dominate the human rabies vaccine market with the largest share during the forecast period. Surge in investment by the Governments in the countries and public sector, programs to eradicate rabies from the region, etc. are propelling the growth of the global market in the North America. Furthermore, rise in awareness, animal vaccination, high health care expenditure etc. are some other factors leading to the expansion of the market in the region. Europe is anticipated to hold a significant share of the global market due to increase in health care expenditure, rise in pet adoption, etc. in the region. Asia Pacific is estimated to register a rapid growth rate during the forecast period. It is a highly lucrative market owing to the high prevalence of rabies, immunization programs induced by the Governments of the countries, growing investment in R&D sector, entry of new vaccine manufacturers in countries such as India, etc.
To obtain a significant position in the global market the key players in the human rabies vaccine market engage in mergers and acquisitions, robust R&D, cost-effective and efficient vaccine products, collaborative partnerships etc. Some of the prominent players operating in the global human rabies vaccine market are Serum Institute of India, Novartis AG, Cadila Pharmaceuticals Ltd., and Merck & Co., Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Vaccines
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017